Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015· article· en· New England Journal of Medicine· Medicine
aff
12,000
citations
Works
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Route
Field
Type
Language
Year range
to
Screen consensus
Sort
Flags
Screening evidence
Direct labels are sparse and unvalidated. Missing labels are unknown.
1 filter active
10,000+ workspage 1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
2017· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
9,109
citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008· article· en· New England Journal of Medicine· Medicine
aff
6,637
citations
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001· article· en· New England Journal of Medicine· Medicine
aff
6,486
citations
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002· article· en· New England Journal of Medicine· Medicine
aff
6,397
citations
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018· article· en· New England Journal of Medicine· Medicine
aff
6,310
citations
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001· article· en· New England Journal of Medicine· Medicine
aff
6,149
citations
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005· article· en· New England Journal of Medicine· Medicine
aff
5,451
citations
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
2014· article· en· New England Journal of Medicine· Medicine
aff
4,611
citations
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001· article· en· New England Journal of Medicine· Medicine
aff
4,568
citations
4,397
citations
Abiraterone and Increased Survival in Metastatic Prostate Cancer
2011· article· en· New England Journal of Medicine· Medicine
aff
4,394
citations
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002· article· en· The Lancet· Biochemistry, Genetics and Molecular Biology
affno abstract
4,163
citations
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
3,883
citations
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007· article· en· Journal of Clinical Oncology· Medicine
affabout
3,859
citations
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
2009· article· en· Obstetrical & Gynecological Survey· Medicine
aff
3,658
citations
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016· article· en· New England Journal of Medicine· Medicine
aff
3,629
citations
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013· article· en· New England Journal of Medicine· Medicine
aff
3,474
citations
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
2012· article· en· New England Journal of Medicine· Medicine
aff
3,309
citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019· article· en· The Lancet· Medicine
affno abstract
3,040
citations
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003· article· en· The Lancet· Medicine
affno abstract
2,984
citations
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
2008· article· en· Journal of Clinical Oncology· Medicine
aff
2,963
citations
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018· review· en· The Lancet· Medicine
affno abstract
2,818
citations
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001· article· en· The Lancet· Medicine
affno abstract
2,808
citations
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003· article· en· The Lancet· Medicine
affno abstract
2,614
citations